Psychological reaction to chronic skin disorders

Porter, Judith R.; Beuf, Ann H.; Nordlund, James J.; Lerner, Aaron B.

doi:10.1016/0163-8343(79)90081-1

Cited by 133 publications

(131 citation statements)

References 13 publications

Supporting

Mentioning

122

Contrasting

Unclassified

Order By: Relevance

“…In a study done in cases with vitiligo, 40% of cases were found to be depressive and had low self-esteem (29). In the study of Sukan and Maner (11) which they compared patients with vitiligo and chronic urticaria for SCID-I diagnoses, they found high prevalence of psychiatric morbidity such as social phobia (26%), dysthymia (26%), obsessive compulsive disorder (26%) and specific phobia (36%) in cases with vitiligo.…”

Section: Discussionmentioning

confidence: 99%

Psychiatric morbidity in patients with vitiligo / Vitiligolu hastalarda psikiyatrik morbidite

Balaban¹,

Atagün²,

Özgüven³

et al. 2011

Dusunen Adam

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Psychiatric morbidity in patients with vitiligo / Vitiligolu hastalarda psikiyatrik morbidite

Balaban¹,

Atagün²,

Özgüven³

et al. 2011

Dusunen Adam

View full text Add to dashboard Cite

“…30 In an attempt to hide their vitiligo lesions, many patients wore adapted clothing and applied large quantities of cosmetics. [24][25][26] There is a need for accessible, accurate, community-based education about the natural history of vitiligo, the effectiveness of treatments and its expected duration. The provision of such information facilitates therapeutic selection by the patient, enhancing their understanding of treatment options and influencing the public attitude towards this disease.…”

Section: Resultsmentioning

confidence: 99%

“…Similar results were shown in Porter et al, Prasad et al, Mattoo et al, Finlay et al studies. 2,4,19,20 Vitiligo patients were having negative beliefs about their overall look. Concern regarding their looking different from others and getting a stare was of a concern in patients suffering from vitiligo.…”

Section: Feeling Domainmentioning

confidence: 99%

Assessment of quality of life in Indian patients with vitiligo, an observational study

Trivedi¹,

Rana²,

Thakkar³

et al. 2017

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

INTRODUCTIONVitiligo is a common depigmenting skin disorder characterized by acquired, idiopathic, progressive, circumscribed hypomelanosis of the skin and hair. It occurs worldwide, with an incidence of 0.5% to 2.0%. 1 Vitiligo is disfiguring in all races but particularly more so in dark skinned people because of strong contrast.2 Vitiligo may entail significant psychosocial consequences. Vitiligo is a social stigma and is associated with a decreased quality of life, especially when lesions are located over the face; thus, it may affect the quality of social and personal life depending on the patient's perception. 3In India and perhaps elsewhere also men, women and children with vitiligo face severe psychological and social problems. Many vitiligo patients felt distressed and . Vitiligo patients presented with symptoms of pain, irritation and itching (P<0.0001). Vitiligo patients when assessed for feeling domain were significantly embarrassed for their overall look and appearance. (P < 0.0001). When Personal relationship domain was analysed physical contact was a major concern (P <0.002). Patients suffering from Vitiligo were significantly worried about spread of vitiligo and occurrence of cancer (P<0.0001). Therapy for Vitiligo was time consuming time and was a work place challenge for the patients (P <0.0001). The reliability of VQLQ in our study was Cronbach's α coefficient was 0.876. Conclusions: QoL impairment was relatively high in vitiligo patients. Medical intervention and counselling should focus to improve feelings, personal relationship, anxiety, school/work, leisure and symptom domains.

show abstract

“…Although neither life-threatening nor symptomatic (except that depigmented patches burn easily when exposed to the sun), vitiligo can be cosmetically and psychologically devastating, 378 resulting in reduced self-esteem, 379 poor body image, 380 difficulties in sexual relationships 381 and feelings of social isolation and stigmatisation. 382 Some people with vitiligo experience discrimination in employment, particularly in jobs where they have to deal with the public.…”

Section: Impactmentioning

confidence: 99%

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Kim

Batchelor

Bath‐Hextall

et al. 2016

Programme Grants Appl Res

View full text Add to dashboard Cite

Programme Grants for Applied ResearchISSN 2050-4322 (Print) ISSN 2050-4330 (Online) This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full PGfAR archive is freely available to view online at www.journalslibrary.nihr.ac.uk/pgfar. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Programme Grants for Applied Research journalReports are published in Programme Grants for Applied Research (PGfAR) if (1) they have resulted from work for the PGfAR programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors. Programme Grants for Applied Research programmeThe Programme Grants for Applied Research (PGfAR) programme, part of the National Institute for Health Research (NIHR), was set up in 2006 to produce independent research findings that will have practical application for the benefit of patients and the NHS in the relatively near future. The Programme is managed by the NIHR Central Commissioning Facility (CCF) with strategic input from the Programme Director.The programme is a national response mode funding scheme that aims to provide evidence to improve health outcomes in England through promotion of health, prevention of ill health, and optimal disease management (including safety and quality), with particular emphasis on conditions causing significant disease burden.For more information about the PGfAR programme please visit the website: http://www.nihr.ac.uk/funding/programme-grants-forapplied-research.htm This reportThe research reported in this issue of the journal was funded by PGfAR as project number RP-PG-0407-10177. The contractual start date was in September 2008. The final report began editorial review in April 2014 and was accepted for publication in April 2016. As the funder, the PGfAR programme agreed the research questions and study designs in advance with the investigators. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The PGfAR editors and production house have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the final report document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, CCF, NETSCC, PGfAR or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, ...

show abstract

Psychological reaction to chronic skin disorders

Cited by 133 publications

References 13 publications

Psychiatric morbidity in patients with vitiligo / Vitiligolu hastalarda psikiyatrik morbidite

Psychiatric morbidity in patients with vitiligo / Vitiligolu hastalarda psikiyatrik morbidite

Assessment of quality of life in Indian patients with vitiligo, an observational study

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Contact Info

Product

Resources

About